Supplemental

Interest Paid

West Pharmaceutical Services Interest Paid remained flat by 0.0% to $75.00K in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 40.0%, from $125.00K to $75.00K. Over 4 years (FY 2021 to FY 2025), Interest Paid shows a downward trend with a -56.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementCash Flow Statement
SectionSupplemental
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2017
Last reportedQ4 2025

How to read this metric

Increasing interest payments relative to debt levels may signal rising interest rates or a higher cost of borrowing.

Detailed definition

The total cash outflow for interest payments on debt obligations during the period. This metric highlights the cash cost...

Peer comparison

Used to compare the cost of debt and interest coverage ratios against industry peers.

Metric ID: interest_paid

Historical Data

5 years
 FY'21FY'22FY'23FY'24FY'25
Value$8.00M$6.60M$6.00M$500.00K$300.00K
YoY Change-17.5%-9.1%-91.7%-40.0%
Range$300.00K$8.00M
CAGR-56.0%
Avg YoY Growth-39.6%
Median YoY Growth-28.7%
Current Streak4+ years decline

Frequently Asked Questions

What is West Pharmaceutical Services's interest paid?
West Pharmaceutical Services (WST) reported interest paid of $75.00K in Q4 2025.
How has West Pharmaceutical Services's interest paid changed year-over-year?
West Pharmaceutical Services's interest paid decreased by 40.0% year-over-year, from $125.00K to $75.00K.
What is the long-term trend for West Pharmaceutical Services's interest paid?
Over 4 years (2021 to 2025), West Pharmaceutical Services's interest paid has grown at a -56.0% compound annual growth rate (CAGR), from $8.00M to $300.00K.
What does interest paid mean?
The total cash paid for interest on debt.